November 07, 2012 at 15:22 PM EST
Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.   

 

Event: 

Lazard Capital Markets 9th Annual Healthcare Conference

Date: 

Tuesday, November 13, 2012

Time:

11:00 a.m. Eastern Time

Location:

The Pierre Hotel, New York, NY



Event: 

Jefferies 2012 Global Healthcare Conference

Date: 

Thursday, November 15, 2012

Time: 

2:20 p.m.  Greenwich Mean Time

Location: 

London, England

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to www.arraybiopharma.com.

CONTACT: Tricia Haugeto 
Array BioPharma Inc.
303-386-1193
thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here